Early markers of cardiovascular damage in obese subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 9, Issue 2, 1999, Pages 78-86

  Licata, G ^a,b   Scaglione, R ^a   Dominguez, L J ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Istituto di Clinica Medica   (Italy)

Author keywords

Cardiovascular damage; Endothelial dysfunction; Left ventricular hypertrophy; Microalbuminuria; Obesity

Indexed keywords

BIOLOGICAL MARKER;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CAROTID ARTERY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INSULIN RESISTANCE; MALE; MORTALITY; OBESITY; PATHOLOGY; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; OBESITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0033107804     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (83)

1. Sowers JR, Epstein MD (1995) Diabetes mellitus and hypertension: an update. Hypertension 26: 869-879
2. Lopez AD (1993) Assessing the burden of mortality from cardiovascular disease. World Health Stat Q 46: 91-96
3. Devereux RB, Alderman MH (1993) Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 88: 1444-1455
4. Aronow WS (1990) Left ventricular hypertrophy: significance in cardiac morbidity and mortality. Postgrad Med 87: 147-158
5. Marban E, Koretsune Y (1990) Cell calcium, oncogenes, and hypertrophy. Hypertension 15: 652-658
6. Barbagallo M, Gupta RK, Resnick LM (1996) Cellular ions in NIDDM: relation of calcium to hyperglycemia and cardiac mass. Diabetes Care 19: 1393-1398
7. 2+ in myocytes from aorticbanded rats. Circulation 94: 2915-2922
8. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Largh JH (1986) Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105: 173-178
9. Levy D (1989) Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. Ann Intern Med 110: 101-107
10. Levy D (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566
11. Agabiti Rosei E, Muiesan ML (1997) Prognostic significance of left ventricular hypertrophy regression. Adv Exp Med Biol 432: 199-205
12. Agabiti Rosei E (1994) Evaluation of the cardiac effects of anti-hypertensive agents. J Cardiovasc Pharmacol 23: S42-S48
13. Granger CB, Karimeddini MK, Smith VE, Shapiro HR, Katz AM, Riba AL (1985) Rapid ventricular filling in left ventricular hypertrophy. I. Physiologic hypertrophy. J Am Coll Cardiol 5: 862-867
14. Siegel D, Cheitlin MD, Black DM, Seeley D, Hearst N, Hulley SB (1990) Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy. Am J Cardiol 65: 742-747
15. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH (1991) Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352
16. Bonow RO, Bacharach SL, Green MV (1981) Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography. Circulation 64: 315-323
17. Fouad FM, Slominsky JM, Tarazi RC (1984) Left ventricular diastolic function in hypertension: Relation to left ventricular mass and systolic function. J Am Coll Cardiol 3: 1500-1506
18. Christian TF, Zinsmeister AR, Miller TD, Clements IP, Gibbons RJ (1990) Left ventricular systolic response to exercise in patients with systemic hypertension without left ventricular hypertrophy. Am J Cardiol 65: 1204-1208
19. Licata G, Scaglione R, Barbagallo M, Parrinello G, Capuana G, Lipari R, Merlino G, Ganguzza A (1991) Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obes 15: 295-302
20. Licata G, Scaglione R, Paterna S, Parrinello G, Indovina A, Dichiara MA, Alaimo G, Merlino G (1992) Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. Int J Cardiol 37: 223-230
21. Bonow RO (1988) Prognostic implications of exercise radionuclide angiography in patients with coronary artery disease. Mayo Clin Proc 63: 630-634
22. Galderisi M, Anderson KM, Wilson PWF, Levy D (1991) Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68: 85-89
23. Licata G, Scaglione R, Parrinello G, Corrao S (1992) Rapid left ventricular filling in untreated hypertensive subjects with or without left ventricular hypertrophy. Chest 102: 1507-1511
24. Scaglione R, Dichiara MA, Indovina A, Lipari R, Ganguzza A, Parrinello G, Capuana G, Merlino G, Licata G (1992) Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J 13: 738-742
25. Licata G, Corrao S, Parrinello G, Scaglione R. (1994) Obesity and cardiovascular diseases. Ann Ital Med Int 9: 29-33
26. Mogensen CE (1984) Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310: 356-360
27. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89-93
28. Yudkin JS, Forrest RD, Jackson CA (1988) Microalbuminuria as predictor of vascular disease in nondiabetic subjects. Lancet 2: 530-533
29. Haffner SM, Stern MP, Gruber MK, Hazuda HP, Mitchell BD, Pattterson JK (1990) Microalbuminuria: potential marker for increased cardiovascular risk factor in non-diabetic subjects? Arteriosclerosis 5: 727-731
30. Ljungman S (1990) Microalbuminuria in essential hypertension. Am J Hypertens 3: 956-960
31. Yoshida Y, Fogo A, Ichikawa I (1989) Glomerular haemodynamics changes vs hypertrophy in experimental glomerular sclerosis. Kidney Int 25: 654-660
32. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM (1994) Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors. Hypertension 23: 195-199
33. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V (1994) Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 344: 14-18
34. Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, Arnone S, D'Auert MD, Licata G (1995) Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes 19: 403-409
35. Cerasola G, Cottone S (1997) Microalbuminuria as a marker of vascular damage in hypertension: influence of blood pressure and metabolic patterns. Nutr Metab Cardiovasc Dis 7: 92-95
36. Gibbons GH, Dzau VJ (1994) Mechanisms of disease: emerging concept of vascular remodeling. N Eng J Med 330: 1433-1438
37. Bennett MR, Evan GT, Schwartz SM (1995) Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest 95: 2266-2274
38. Brooks PC, Clark RAF, Cheresh DA, (1994) Requirement of vascular integrin avb3 for angiogenesis. Science 264: 569-571
39. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA (1991) Use of sonography to evaluate carotid athesclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 9: 1155-1163
40. Pinto A, Scaglione R, Galati D, Paterna S, Parrinello G, Arnone S, Licata G (1995) Evaluation of regional haemodynamics and alterations of vascular wall of the lower limbs in hypertensive subjects. Eur Heart J 16: 1692-1697
41. Di Silvestre G, Cecala M, Amato P, Licata A, Scaglione R, Pinto A, Parrinello G, Licata G (1996) Ultrasonographic assessment of common carotid artery wall in hypertensives with familial hypercholesterolaemia. Am J Hypertens 9: 62A
42. Howard G, Ryu JE, Evans GW, McKinney WM, Toole JF, Murros KE, Crouse JR (1990) Extracranial carotid atherosclerosis in patients with and without transient ischaemic attacks and coronary artery disease. Arteriosclerosis 10: 714-719
43. Khoury Z, Schwartz R, Gottlieb S, Chenzbraun A, Stern S, Keren A (1997) Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 80: 1429-1433
44. Zanchetti A (1997) Intermediate endpoints for atherosclerosis in hypertension. Blood Press 2: 97-102
45. Avellone G, Di Garbo V, Cordova R (1995) Sindrome trombofilica in pazienti affetti da pregresso infarto del miocardio con o senza lesioni aterosclerotiche carotidee. Cardiologia 40: 845-850
46. Lüscher TF (1990) Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension? Am J Hypertens 3: 317-330
47. Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526
48. Radomski MW, Palmer RMJ, Moncada S (1987) Endogenous nitric oxide inhibits platelet adhesion to vascular endothelium. Lancet 2: 1057-1068
49. Garg UC, Hassid A (1989) Nitric oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777
50. Dubey OB, Lüscher TF (1993) Nitric oxide inhibits angiotensin II-induced migration of vascular smooth muscle cells. Hypertension 22: 412-415
51. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leucocyte adhesion. Proc Natl Acad Sci USA 88: 4651-4655
52. De Caterina R, Libby P, Peng HB, Thannical VJ, Rajavashisth TB, Gimbrone MA, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation 90: 60-68
53. Taddei S, Virdis A, Mattei P, Salvetti A (1993) Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933
54. Treasure CB, Klein JL, Vita JA, Manoukian SV, Remvick GH, Selwyn AP, Ganz P, Alexander RW (1993) Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87: 86-93
55. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA (1993) Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 87: 1468-1474
56. Linder L, Kiowski W, Buhler FR, Luscher TF (1990) Indirect evidence for the release of endothelium-derived relaxing factor in the human forearm circulation in vivo: Blunted response in essential hypertension. Circulation 81: 1762-1767
57. Taddei S, Virdis A, Mattei P, Ghiadoni L, Gennari A, Basile-Fasolo C, Sudano I, Salvetti A (1997) Aging and endothelial function in normotensive subjects and essential hypertensive patients. Circulation 91: 1981-1987
58. Taddei S, Virdis A, Mattei P, Ghiadoni L, Sudano I, Salvetti A (1996) Defective L-arginine-nitric oxide pathway in offsprings of essential hypertensive patients. Circulation 94: 1298-1303
59. Moller DE, Flier JS (1991) Insulin resistance-mechanisms, syndromes and implications. N Engl J Med 325: 937-941
60. Eschwege E, Richard JL, Thibult N, Ducimetière P, Warnet JM, Claude JR, Rosselin GE (1985) Coronary heart disease plasma insulin levels: the Paris prospective study, ten years later. Horm Metab Res 15: 41-61
61. Pyorala K (1989) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131-141
62. Ducimetière P, Eschwege R, Papoz L, Richard JL, Claude JR, Rosselin G (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205-210
63. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passen M (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702-706
64. Cigolini M, Seidell JC, Targher G, Deslypere JP, Ellsinger BM, Charzewska J, Gruz A, Björntorp P (1995) Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: the European fat distribution study. Metabolism 44: 35-40
65. King GL, Goodman DA, Buzney S, Moses A, Kahn CR (1985) Receptors and growth-promoting effects of insulin and insulin like growth factors in cells from bovine retinal capillaries and aorta. J Clin Invest 75: 1028-1036
66. Baron AD, Brechtel G (1993) Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol 265: 1321-1336
67. Trovati M, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Piretto V, Cavalot F, Anfossi G (1995) Impaired insulin-induced platelet antiaggregating effect in obesity and in obese NIDDM patients. Diabetes 44: 1318-1322
68. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL (1992) Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 19: 621-627
69. Landsberg L, Young JB (1985) Insulin mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous systemic activity. Int J Obes 9(Suppl 2): 63-68
70. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregory M (1989) Insulin and renal sodium retention in obese adolescents. Hypertension 14: 367-374
71. Licata G, Volpe M, Scaglione R, Rubattu S (1994) Salt regulating hormones in young normotensive obese subjects. Effects of saline load. Hypertension 23 (suppl 1): 20-24
72. Steinberg HO, Chaker H, Learning R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610
73. Zeng G, Quon MJ (1996) Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898
74. Trovati M, Anfossi G, Massucco P, Mattiello L, Costamagna C, Piretto V, Mularoni E, Cavalot F, Bosia A, Ghigo D (1997) Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′, 5′-cyclic monophosphate and adenosine-3′, 5′-cyclic monophosphate. Diabetes 46: 742-749
75. Brunner HR, Laragh JH, Baer L (1972) Essential hypertension: renin and aldosterone heart attack and stroke. N Engl J Med 286: 441-449
76. Brunner HR, Sealey JE, Laragh JH (1973) Renin as a risk factor in essential hypertension: more evidence. Am J Med 55: 295-302
77. Gavras H, Kremer D, Brown JJ, Gray B, Lever AF, MacAdam RF Medina A, Morton JJ, Robertson JI (1975) Angiotensin and norepinephrine induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J 89: 321-332
78. Camargo MJ, Campbell WG, Volpe M, Muller FB (1990) (abs) Abnormal renin secretory response to high sodium diet in stroke prone spontaneously hypertensive rats. Kidney Int 37: 383A
79. Volpe M, Rubattu S, Mirante A, De Luca N, Condorelli M (1992) (abs) Early impairment of sodium handling in stroke-prone spontaneously hypertensive rats. Am J Hypertens 5: 48A-
80. Kurtz TW, Morris RC, Pershadsingh HA (1989) The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 13: 896-901
81. Volpe M, Lembo G, De Luca N, Lamenza F, Tritto C, Ricciardelli B, Molaro M, De Campora P, Condorelli G, Rendina V (1991) Abnormal hormonal and renal responses to saline load in hypertensive patients with parental history of cardiovascular accidents. Circulation 84: 92-100
82. Stier CT, Benter IF, Ahmad S (1989) Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13: 115-121
83. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH (1991) Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 324: 1098-1104